emerg
novel
coronaviru
led
pandem
infect
two
million
peopl
worldwid
less
four
month
pose
major
threat
healthcar
system
compound
shortag
avail
test
caus
numer
healthcar
worker
unnecessarili
selfisol
provid
roadmap
instruct
research
institut
repurpos
midst
crisi
collabor
partner
hospit
establish
diagnost
laboratori
har
exist
expertis
viru
handl
robot
pcr
data
scienc
deriv
rapid
high
throughput
diagnost
test
pipelin
detect
patient
suspect
pipelin
use
detect
combin
nosethroat
swab
endotrach
secret
bronchoalveolar
lavag
fluid
notabl
reli
seri
inhous
buffer
viru
inactiv
extract
viral
rna
therebi
reduc
depend
commerci
supplier
time
global
shortag
use
commerci
rtpcr
assay
bgi
result
report
bespok
onlin
web
applic
integr
healthcar
digit
system
strategi
facilit
remot
report
thousand
sampl
day
turnaround
time
hour
univers
applic
laboratori
worldwid
end
outbreak
pneumonia
observ
wuhan
china
pathogen
confirm
novel
coronaviru
strain
world
health
organ
name
pathogen
sever
acut
respiratori
syndrom
coronaviru
rapidli
spread
respiratori
tract
pathogen
led
pandem
togeth
high
hospit
rate
requir
critic
care
impos
major
challeng
healthcar
system
worldwid
comprehens
reliabl
test
essenti
identifi
viru
individu
present
symptom
hospit
guid
commun
intervent
contain
spread
perform
enhanc
surveil
program
healthcar
worker
maintain
workforc
safe
deliv
care
requir
place
unpreced
demand
test
capabl
countri
demand
diagnost
laboratori
coupl
global
shortag
commerci
kit
reagent
reduc
commerci
flight
cargo
capac
intern
competit
test
resourc
render
test
capac
mani
countri
inadequ
deal
outbreak
effect
franci
crick
institut
fci
biomed
research
institut
dedic
discoveri
biolog
underli
human
health
situat
central
london
epicent
uk
pandem
fci
elect
repurpos
scientif
technic
resourc
support
immedi
healthcar
need
partner
hospit
univers
colleg
london
hospit
outbreak
provid
endtoend
pipelin
clinic
diagnost
test
would
result
increas
test
capac
could
meet
local
demand
allow
new
surveil
program
healthcar
worker
implement
describ
roadmap
crick
consortium
deliv
pipelin
highlight
import
consider
implement
similar
solut
research
institut
worldwid
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doiorg
key
find
solut
partnership
creat
fci
major
london
healthcar
provid
togeth
clinic
virolog
expertis
univers
colleg
london
hospit
nation
health
servic
trust
accredit
clinic
diagnost
laboratori
health
servic
laboratori
form
crick
consortium
ccc
partnership
effect
remov
barrier
clinic
translat
facilit
rapid
implement
robust
end
end
test
within
ten
day
oversight
accredit
laboratori
importantli
also
allow
resourc
expertis
mobilis
meet
local
healthcar
need
notabl
strength
ccc
pipelin
swab
either
dri
proprietari
viru
transport
media
vtm
taken
hospit
site
local
drivethrough
station
submit
accredit
report
laboratori
transfer
fci
specimen
barcod
track
proceed
immedi
viral
inactiv
autom
extract
viral
rna
use
seri
inhous
buffer
rtpcr
quantifi
rna
result
access
custommad
onlin
web
portal
facilit
data
analys
remot
panel
train
report
return
refer
laboratori
speed
precis
pipelin
permit
report
thousand
samplesday
adopt
process
wide
use
mani
research
laboratori
worldwid
free
depend
suppli
chain
constraint
facilit
acceler
establish
crick
consortium
pipelin
within
fortnight
partner
accredit
diagnost
provid
health
servic
laboratori
hsl
healthcar
trust
clinic
virolog
depart
univers
colleg
london
hospit
uclh
hsl
evalu
valid
rtpcr
assay
diagnost
n
gene
assay
act
refer
laboratori
concept
ccc
pipelin
uclh
provid
access
barcod
swab
prebook
onto
laboratori
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
work
partnership
hsl
uclh
uka
accredit
lab
alreadi
test
scope
sampl
receiv
commun
hsl
accredit
ccc
assay
valid
exist
hsl
test
given
urgent
timefram
requir
implement
test
possibl
secur
clinic
laboratori
accredit
fci
appropri
standard
iso
us
equiv
capclia
howev
full
measur
taken
ensur
ccc
test
evalu
verifi
perform
diagnost
use
environ
adher
equival
intern
standard
overseen
audit
hsl
measur
implement
advic
oversight
regist
profession
exist
nearbi
iso
accredit
medic
laboratori
includ
write
follow
clinic
diagnost
standard
oper
procedur
sop
everi
stage
pipelin
sampl
recept
process
result
report
qualifi
clinic
scientist
prior
result
sent
patient
hsl
addit
sop
follow
sampl
storag
dispos
materi
batch
certif
reagent
incid
report
appropri
risk
assess
train
compet
assess
procedur
establish
document
record
sheet
creat
document
receipt
batch
accept
test
startend
use
date
key
reagent
consum
inventori
key
equip
compil
appropri
includ
detail
servic
calibr
record
system
also
establish
control
key
document
version
implement
distribut
acknowledg
audit
trail
sampl
test
equip
use
consumablereag
batch
record
untoward
incidentsissu
thu
facilit
appropri
investig
rectif
recurr
prevent
sampl
barcod
track
use
crick
clariti
lim
system
key
document
avail
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
assur
pipelin
perform
collabor
genqa
follow
checklist
nonaccredit
laboratori
lab
ccc
workflow
inspect
qualifi
uka
assessor
genqa
guidelin
verifi
complianc
equival
standard
protocol
describ
sampl
process
ccc
pipelin
posit
neg
control
ad
prior
rtpcr
procedur
scale
requir
increas
throughput
ccc
pipelin
illustr
figur
procedur
carri
within
class
ii
safeti
cabinet
train
authoris
personnel
person
protect
equip
ppe
time
inspect
sampl
integr
swab
remov
sampl
contain
vtm
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
method
swab
submit
dri
immers
inactiv
buffer
follow
transfer
barcod
collect
tube
inactiv
viral
sampl
visual
check
confirm
ident
one
sampl
process
time
avoid
risk
sampl
swap
liquid
wast
decontamin
surfanio
inactiv
individu
viral
sampl
move
separ
area
rna
extract
specimen
inactiv
oper
minut
use
method
detail
supplementari
method
first
step
consist
transfer
inactiv
lysat
individu
sampl
tube
nunc
polypropylen
storag
plate
allow
batch
process
extract
rna
use
rtpcr
assay
primer
fluoresc
probe
bgi
kit
design
highli
conserv
region
primer
sequenc
locat
within
region
one
uniqu
site
genom
qpcr
bgi
kit
oligonucleotid
probe
fam
fluorophor
report
attach
end
specif
primer
probe
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
set
human
betaactin
includ
intern
refer
vic
fluorophor
report
end
use
intern
control
permit
swab
failur
differenti
specimen
critic
deal
dri
wet
swab
batch
sampl
run
posit
control
provid
kit
samplefre
eluat
blank
control
batch
sampl
run
duplic
rtpcr
protocol
use
abi
quantstudio
take
min
complet
allow
quantit
assess
specimen
refer
plate
run
altern
day
qualiti
control
step
supplementari
method
ccc
test
valid
n
gene
assay
develop
refer
laboratori
health
servic
laboratori
hsl
n
gene
assay
high
throughput
rtpcr
assay
run
holog
panther
fusion
platform
use
open
access
function
allow
use
custom
primer
probe
target
nucleocapsid
n
gene
includ
holog
intern
control
primer
probe
n
gene
tctggtaaaggccaacaacaa
n
gene
tgtatgctttagtggcagtacg
n
gene
probe
fam
ctgtcactaagaaatctgctgctgaggc
n
gene
assay
previous
valid
assay
public
health
england
run
colindal
refer
laboratori
initi
qualiti
control
assess
integr
run
perform
establish
whether
intern
extern
control
pass
set
criteria
blank
control
ct
valu
fam
vic
intern
control
channel
must
neg
rang
data
avail
fam
data
avail
vic
criteria
line
manufactur
instruct
http
posit
control
standard
curv
channel
fam
vic
channel
must
sshape
ct
valu
higher
respect
requir
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
follow
initi
qualiti
control
perform
first
report
second
report
abl
access
data
duplic
run
web
applic
github
access
avail
request
supplementari
method
evalu
upload
result
excel
file
role
second
report
includ
check
posit
neg
control
describ
confirm
accept
criteria
pass
overal
plate
curv
suggest
appropri
pcr
amplif
ensur
complet
audit
trail
sampl
process
step
second
report
manual
set
threshold
level
background
nonexponenti
amplif
export
data
refer
laboratori
posit
neg
sampl
failur
result
gener
automat
base
ct
valu
comment
xl
result
upload
report
system
refer
laboratori
logic
onlin
report
system
ensur
repeat
sampl
request
discord
result
across
duplic
run
step
pipelin
allow
result
patient
gener
within
minut
clinic
report
authoris
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
streamlin
pipelin
ensur
everi
sampl
individu
track
hospit
swab
viral
inactiv
sampl
aliquot
barcod
plate
plate
rna
extract
barcod
plate
rtpcr
final
remot
report
sampl
request
sent
refer
laboratori
winpath
system
upload
secur
ftp
site
creat
entri
genolog
claritylim
sampl
track
databas
system
swab
specimen
regist
sampl
queue
sampl
receiv
sampl
recept
area
scan
updat
databas
critic
assess
damag
sampl
scan
mark
remov
process
sampl
subject
viral
inactiv
transfer
barcod
plate
subsequ
step
rna
extract
rtpcr
claritylim
commerci
licens
webbas
sampl
track
softwar
instal
onpremis
applic
integr
franci
crick
intern
system
sampl
manag
system
use
configur
integr
exist
pipelin
requir
ccc
test
benchmark
refer
laboratori
n
gene
assay
use
current
clinic
sampl
process
parallel
use
holog
panther
platform
specimen
process
duplic
ccc
pipelin
inactiv
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
viru
rna
extract
rtpcr
figur
second
batch
clinic
specimen
process
independ
figur
parallel
test
sampl
process
n
gene
assay
holog
panther
platform
refer
laboratori
assay
contain
human
intern
control
mechan
test
swab
failur
n
gene
assay
part
valid
untest
blank
swab
submit
yield
neg
result
refer
laboratori
assay
due
absenc
signal
human
intern
control
classifi
swab
fail
ccc
test
figur
figur
next
monitor
test
specif
live
pipelin
run
assess
ct
valu
amplif
well
contain
elut
buffer
rtpcr
master
mix
nonsampl
well
twentyfour
twentyf
nonsampl
well
process
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
initi
live
run
undetermin
ct
valu
reflect
absenc
amplifi
product
well
supplementari
figur
sampl
water
test
alongsid
posit
control
assess
occurr
inher
latecycl
amplif
nonspecif
signal
use
rtpcr
kit
late
ct
signal
intern
control
target
observ
well
respect
supplementari
figur
b
experi
repeat
use
guanidinium
inactiv
buffer
rna
elut
buffer
signal
present
well
respect
supplementari
figur
overlap
seen
target
confirm
effort
ascertain
ccc
test
sensit
particularli
relev
specimen
low
viral
concentr
linear
analysi
perform
test
serial
dilut
rna
extract
posit
patient
follow
rtpcr
start
ct
valu
origin
sampl
linear
respons
observ
dilut
origin
rna
eluat
figur
reproduc
ccc
test
measur
use
sampl
patient
confirm
diagnosi
sampl
dilut
fold
viral
inactiv
buffer
individu
aliquot
subject
independ
repeat
ccc
pipelin
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
rna
extract
rtpcr
determin
ct
valu
figur
coeffici
variat
ccc
test
precis
calcul
describ
partnership
biomed
research
institut
clinic
virologist
diagnost
laboratori
formul
meet
healthcar
need
viral
pandem
present
sensit
specif
highthroughput
pipelin
turnaround
detect
rna
individu
suspect
infect
number
approach
establish
detect
specimen
sever
test
current
avail
use
differ
approach
inactiv
viru
well
rna
extractionfre
approach
discuss
key
consider
inform
specif
approach
adopt
ccc
pipelin
viral
inactiv
perform
contain
level
suit
compat
local
capac
train
staff
fci
appropri
risk
assess
uniqu
differ
research
institut
swab
inactiv
prior
transport
pipelin
could
perform
contain
level
facil
adapt
laboratori
worldwid
supplementari
method
protocol
also
exist
altern
viral
inactiv
method
use
heat
demonstr
potenti
ccc
pipelin
applic
avail
guanidinium
may
limit
ccc
test
use
seri
homemad
buffer
autom
rna
extract
routin
rtpcr
use
kit
bgi
circumv
depend
reagent
may
short
suppli
pandem
time
write
import
bottleneck
perform
pcr
test
detect
shortag
kit
rna
extract
develop
hous
rna
extract
protocol
use
magnet
silica
bead
gbioscienc
also
valid
assay
serasil
mag
bead
ge
healthcarecytiva
serv
reliabl
substitut
rna
extract
use
silica
base
protocol
develop
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
boom
method
concentr
guanidinium
thiocyan
serv
viru
rnase
inactiv
agent
promot
bind
nucleic
acid
silica
altern
method
solidphas
revers
immobil
spri
take
advantag
nucleic
acid
bind
magnet
bead
coat
carboxyl
group
presenc
polyethylen
glycol
salt
test
beckman
rnaclean
xp
spri
magnet
bead
beckman
found
compat
viru
inactiv
solut
viral
rna
could
purifi
follow
manufactur
recommend
moreov
protocol
exist
product
either
type
magnet
bead
inexpens
access
start
materi
therefor
design
pipelin
use
common
reagent
automat
wide
avail
liquid
handl
platform
allow
implement
larg
number
biomed
laboratori
suitabl
robot
platform
reprogam
use
univers
applic
approach
could
allow
resili
respons
futur
critic
event
even
countri
particular
resourc
may
limit
select
appropri
pcr
assay
detect
bgi
kit
base
accredit
laboratori
readi
set
valid
data
experi
primer
use
ccc
test
target
enabl
detect
full
length
genom
antigenom
rna
wherea
n
gene
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
assay
also
target
abund
subgenom
rna
consist
n
gene
assay
slightli
sensit
ccc
assay
limit
detect
figur
sampl
time
adequaci
like
import
determin
fals
neg
qpcr
sensit
ccc
test
includ
control
cellular
rna
betaactin
serv
partial
proxi
sampl
adequaci
although
high
sensit
assay
limit
detect
could
impact
identif
low
level
viral
shed
beyond
assay
limit
detect
sampl
unlik
produc
infecti
viru
moreov
pcr
test
mildli
symptomat
hcw
recommend
beyond
day
onset
therefor
believ
bgi
pcr
exhibit
adequ
sensit
current
clinic
algorithm
high
throughput
rtpcr
assay
plate
format
potenti
screen
deliv
test
process
acquir
accredit
typic
assess
time
span
rule
extend
exist
iso
cliacap
scope
partner
institut
vari
countri
wherev
possibl
clinic
accredit
sought
research
institut
seek
establish
clinic
test
whilst
pursu
process
approach
implement
process
line
intern
accredit
standard
process
remain
supervis
partner
accredit
laboratori
health
inform
system
epic
electron
medic
record
use
uclh
interfac
laboratori
inform
manag
system
winpath
enabl
sampl
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
titrat
curv
tenfold
serial
dilut
patient
sampl
carri
refer
laboratori
follow
rna
extract
rtpcr
perform
determin
linear
detect
process
use
bgi
kit
b
dot
plot
show
assay
precis
five
aliquot
one
posit
sampl
process
independ
repeat
rna
extract
rtpcr
use
bgi
kit
determin
precis
ccc
test
data
shown
target
left
intern
control
target
right
cv
coeffici
variat
consortium
test
illustr
result
call
posit
refer
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
amplif
plot
well
plate
four
column
fold
serial
dilut
column
neg
control
run
parallel
differ
batch
rtpcr
kit
bgi
b
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
